Inhibrx (INBX) Surges After Ozekibart Cuts Cancer Progression Risk by 52%
Inhibrx Inc. (NASDAQ:INBX) is a clinical-stage biopharmaceutical company focused on developing a new generation of therapeutic candidates designed…
Addex Therapeutics (ADXN) is on the Brink of a Breakout
Addex Therapeutics Ltd. (NASDAQ:ADXN) is a clinical-stage biopharmaceutical company based in Geneva, Switzerland, specializing in the discovery and…
Picard Medical (PMED) Plunges 59.77% in One Day
Picard Medical Inc. (NASDAQ:PMED) is an emerging medical technology company focused on transforming the treatment landscape for men’s…
Coya Therapeutics (COYA) Could Be the Next 5X Biotech
Coya Therapeutics Inc. (NASDAQ:COYA) is a clinical-stage biotechnology company pioneering a new class of therapies designed to harness…
Teladoc Health (TDOC) Posts $626.4M in Quarterly Revenue
Teladoc Health Inc. (NYSE:TDOC) is a global pioneer in virtual healthcare and one of the most influential companies…
Sagimet Biosciences (SGMT) Set for 273% Surge After Buy Rating
Sagimet Biosciences Inc. (NASDAQ:SGMT) is a clinical-stage biopharmaceutical company dedicated to developing transformative therapies that target the underlying…
X4 Pharma (XFOR) Targets 44% Annual Growth as Analysts See Upside
X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) is a late-stage clinical biopharmaceutical company founded with a mission to develop innovative therapies…
Tenax (TENX) Could Be the Best-Funded Microcap in Biotech
Tenax Therapeutics, Inc. (NASDAQ:TENX) is a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapies for life-threatening…
Capricor Therapeutics (CAPR) Near All-Time Lows
Capricor Therapeutics (NASDAQ:CAPR) is a biotechnology company founded with a mission to develop transformative cell and exosome-based therapies…
Windtree (WINT) Targets Profitability After Eliminating $8.8M in R&D Costs
Windtree Therapeutics Inc. (NASDAQ:WINT) is a diversified life sciences and emerging environmental services company with a long-established foundation…
Sight Sciences (SGHT) Surges 37% in One Month
Sight Sciences Inc. (NASDAQ:SGHT) is a medical technology company dedicated to transforming the treatment of eye diseases through…
SELLAS (SLS) Surged 40% After Hours on New AML Data
SELLAS Life Sciences Group Inc. (NASDAQ:SLS) is a late-stage clinical biopharmaceutical company focused on developing novel cancer immunotherapies designed…
Artiva Biotherapeutics (ARTV) Rockets 116% in One Day
Artiva Biotherapeutics Inc. (NASDAQ:ARTV) is a clinical-stage biotechnology company pioneering the development of off-the-shelf, allogeneic natural killer (NK)…
Addex Therapeutics (ADXN) Targets $330 Million Milestone Payouts
Addex Therapeutics Ltd (NASDAQ:ADXN) is a clinical-stage biopharmaceutical company headquartered in Geneva, Switzerland, focused on discovering and developing innovative…
Arcadia Biosciences (RKDA) Surges 53%, But EBITDA Is Still -$5.9 Million
Arcadia Biosciences Inc. (NASDAQ:RKDA) is an agricultural biotechnology company founded in 2002 with the mission of developing innovative,…
Bright Minds Biosciences (DRUG) Surges 158.8% in 12 Weeks
Bright Minds Biosciences Inc. (NASDAQ:DRUG) is a biotechnology company focused on developing next-generation therapeutics for neurological and psychiatric disorders…
Vanda Pharmaceuticals (VNDA) Targets 300% Upside with Breakthrough FDA Framework Deal
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) is a biopharmaceutical company focused on the development and commercialization of innovative therapies that…
Delcath (DCTH) Revenue Surges with 87% Gross Margin and Zero Debt Balance Sheet
Delcath Systems Inc. (NASDAQ:DCTH) is a specialty pharmaceutical and medical device company focused on developing and commercializing innovative therapies…